Target Price | $19.17 |
Price | $4.28 |
Potential |
347.82%
register free of charge
|
Number of Estimates | 6 |
6 Analysts have issued a price target scPharmaceuticals, Inc. 2025 .
The average scPharmaceuticals, Inc. target price is $19.17.
This is
347.82%
register free of charge
$25.00
484.11%
register free of charge
$16.00
273.83%
register free of charge
|
|
A rating was issued by 6 analysts: 6 Analysts recommend scPharmaceuticals, Inc. to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the scPharmaceuticals, Inc. stock has an average upside potential 2025 of
347.82%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 13.59 | 39.39 |
189.84% | ||
EBITDA Margin | -403.02% | -137.18% |
65.96% | ||
Net Margin | -377.62% | -119.28% |
68.41% |
6 Analysts have issued a sales forecast scPharmaceuticals, Inc. 2024 . The average scPharmaceuticals, Inc. sales estimate is
This results in the following potential growth metrics:
2 Analysts have issued an scPharmaceuticals, Inc. EBITDA forecast 2024. The average scPharmaceuticals, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 scPharmaceuticals, Inc. Analysts have issued a net profit forecast 2024. The average scPharmaceuticals, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -1.42 | -1.30 |
9.23% | 8.45% | |
P/E | negative | |
EV/Sales | 5.51 |
4 Analysts have issued a scPharmaceuticals, Inc. forecast for earnings per share. The average scPharmaceuticals, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the scPharmaceuticals, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
scPharmaceuticals, Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.